TY - JOUR T1 - COVID-19 lockdown impact on the physical activity of adults with progressive muscle diseases JF - BMJ Neurology Open JO - BMJ Neurol Open DO - 10.1136/bmjno-2021-000140 VL - 3 IS - 1 SP - e000140 AU - Sarah F Roberts-Lewis AU - Mark Ashworth AU - Claire M White AU - Michael R Rose Y1 - 2021/03/01 UR - http://neurologyopen.bmj.com/content/3/1/e000140.abstract N2 - Introduction This short article summarises findings about reduced physical activity of adults with progressive muscle disease as a result of COVID-19 lockdown.Methods As part of an ongoing longitudinal cohort study, we prospectively and objectively measured physical activity using accelerometry at baseline in 2019 and follow-up in 2020. A subset of 85 participants incidentally had follow-up data collected during the first UK COVID-19 lockdown from 23 March to 4 July 2020. Thus, for this cohort we had activity data from before and during the COVID-19 pandemic and we were able to prospectively and accurately quantify the changes in their physical activity.Results Our data highlighted reduced overall activity intensity and reduced light activity time in particular.Conclusions From our findings, we can infer specific evidence-based recommendations about how to redress inactivity secondary to COVID-19 restrictions for adults with progressive muscle diseases. These recommendations are likely to be generalisable to other groups who are vulnerable to functional decline secondary to prolonged inactivity. ER -